Effect of meal timing on pharmacokinetics and pharmacodynamics of tegoprazan in healthy male volunteers

ABSTRACT: Tegoprazan, a novel potassium‐competitive acid blocker, is used to treat acid‐related diseases. However, there is no information on the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of the marketed dosage of tegoprazan under various meal timings in a fed and fasted state. The stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Deok Y., Sunwoo, Jung, Shin, Naree, Kim, Ah R., Kim, Bongtae, Song, Geun S., Jang, In‐Jin, Lee, SeungHwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212751/
https://www.ncbi.nlm.nih.gov/pubmed/33382926
http://dx.doi.org/10.1111/cts.12958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212751/
https://www.ncbi.nlm.nih.gov/pubmed/33382926
http://dx.doi.org/10.1111/cts.12958

Ejemplares similares